AZ
AstraZeneca
AZN13F as of Jun 30, 2026 · next update ~Nov 14
Who's buying AZN
Top funds mostly trimmed AstraZeneca in Q2 (Apr–Jun)
Buying:
FundsInsidersCongress2
- Top funds1 of 3 bought more, 2 sold some. Largest: Causeway Capital Management, $1.8B (19% of its portfolio).
- InsidersNo buys, 1 sale in 12 months. Plus 1 payroll-plan purchase, not counted.
- Congress2 members bought (2 trades), 0 sales in 12 months.
3 funds$1.8B held6.4% avg. weightQ2: 1 bought / 2 sold
13F reports are a snapshot as of Jun 30, 2026; funds may have traded since. Insiders often sell for personal reasons (taxes, diversification, planned sales).
Share price · market data, not from 13F reports
Q2 2026